Lentigo maligna (melanoma): A systematic review and meta-analysis on surgical techniques and presurgical mapping by reflectance confocal microscopy.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
29
09
2022
accepted:
09
01
2023
medline:
17
4
2023
pubmed:
19
1
2023
entrez:
18
1
2023
Statut:
ppublish
Résumé
Because of an increased risk of local recurrence following surgical treatment of lentigo maligna (melanoma) (LM/LMM), the optimal surgical technique is still a matter of debate. We aimed to evaluate the effect of different surgical techniques and reflectance confocal microscopy (RCM) on local recurrence and survival outcomes. We searched MEDLINE, Embase and PubMed databases through 20 May 2022. Randomized and observational studies with ≥10 lesions were eligible for inclusion. Bias assessment was performed using the Methodological Index for Non-Randomized Studies instrument. Meta-analysis was performed for local recurrence, as there were insufficient events for the other clinical outcomes. We included 41 studies with 5059 LM and 1271 LMM. Surgical techniques included wide local excision (WLE) (n = 1355), staged excision (n = 2442) and Mohs' micrographic surgery (MMS) (n = 2909). Six studies included RCM. The guideline-recommended margin was insufficient in 21.6%-44.6% of LM/LMM. Local recurrence rate was lowest for patients treated by MMS combined with immunohistochemistry (<1%; 95% CI, 0.3%-1.9%), and highest for WLE (13%; 95% CI, 7.2%-21.6%). The mean follow-up varied from 27 to 63 months depending on surgical technique with moderate to high heterogeneity for MMS and WLE. Handheld-RCM decreased both the rate of positive histological margins (p < 0.0001) and necessary surgical stages (p < 0.0001). The majority of regional (17/25) and distant (34/43) recurrences occurred in patients treated by WLE. Melanoma-associated mortality was low (1.5%; 32/2107), and more patients died due to unrelated causes (6.7%; 107/1608). This systematic review shows a clear reduction in local recurrences using microscopically controlled surgical techniques over WLE. The use of HH-RCM showed a trend in the reduction in incomplete resections and local recurrences even when used with WLE. Due to selection bias, heterogeneity, low prevalence of stage III/IV disease and limited survival data, it was not possible to determine the effect of the different surgical techniques on survival outcomes.
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
871-883Informations de copyright
© 2023 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Références
Jackett LA, Satgunaseelan L, Roper E, Lo SN, Thompson JF, Scolyer RA. Residual melanoma in wide local excision specimens after ‘complete’ excision of primary cutaneous in situ and invasive melanomas. Pathology. 2022;54(1):71-8.
Star P, Rawson RV, Drummond M, Lo S, Scolyer RA, Guitera P. Lentigo maligna: defining margins and predictors of recurrence utilizing clinical, dermoscopic, confocal microscopy and histopathology features. J Eur Acad Dermatol Venereol. 2021;35(9):1811-20.
Friedman EB, Scolyer RA, Williams GJ, Thompson JF. Melanoma in situ: a critical review and re-evaluation of current excision margin recommendations. Adv Ther. 2021;38(7):3506-30.
McGuire LK, Disa JJ, Lee EH, Busam KJ, Nehal KS. Melanoma of the lentigo maligna subtype: diagnostic challenges and current treatment paradigms. Plast Reconstr Surg. 2012;129(2):288e-99e.
Swetter SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, Elder DE, Gershenwald JE, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019;80(1):208-50.
Robinson M, Primiero C, Guitera P, Hong A, Scolyer RA, Stretch JR, et al. Evidence-based clinical practice guidelines for the management of patients with lentigo maligna. Dermatology. 2020;236(2):111-6.
Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment - update 2022. Eur J Cancer. 2022;170:256-84.
Michielin O, van Akkooi ACJ, Ascierto PA, Dummer R, Keilholz U. Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019;30(12):1884-901.
Punchihewa N, Odhavji S, Upjohn E, Bekhor P. Immunostained frozen sections vs traditional permanent paraffin sections for lentigo maligna treated with Mohs micrographic surgery. Dermatol Surg. 2022;48(1):43-6.
Shin TM, Nugent S, Aizman L, Weiner DM, O'Malley V, Sobanko JF, et al. Mohs micrographic surgery with MART-1 immunostaining has durable low local recurrence rates for in situ and invasive melanomas. J Am Acad Dermatol. 2021;84(1):196-8.
Raziano RM, Clark GS, Cherpelis BS, Sondak VK, Cruse CW, Fenske NA, et al. Staged margin control techniques for surgical excision of lentigo maligna. G Ital Dermatol Venereol. 2009;144(3):259-70.
Guitera P, Moloney FJ, Menzies SW, Stretch JR, Quinn MJ, Hong A, et al. Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy. JAMA Dermatol. 2013;149(6):692-8.
Pellacani G, De Carvalho N, Ciardo S, Ferrari B, Cesinaro AM, Farnetani F, et al. The smart approach: feasibility of lentigo maligna superficial margin assessment with hand-held reflectance confocal microscopy technology. J Eur Acad Dermatol Venereol. 2018;32(10):1687-94.
Sharma AN, Foulad DP, Doan L, Lee PK, Atanaskova Mesinkovska N. Mohs surgery for the treatment of lentigo maligna and lentigo maligna melanoma - a systematic review. J Dermatolog Treat. 2021;32(2):157-63.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
Mathes T, Pieper D. Clarifying the distinction between case series and cohort studies in systematic reviews of comparative studies: potential impact on body of evidence and workload. BMC Med Res Methodol. 2017;17(1):107.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712-6.
Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193-206.
Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323(7304):101-5.
Akhtar S, Bhat W, Magdum A, Stanley PR. Surgical excision margins for melanoma in situ. J Plast Reconstr Aesthet Surg. 2014;67(3):320-3.
Bene NI, Healy C, Coldiron BM. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases. Dermatol Surg. 2008;34(5):660-4.
Durkin JR, Tchanque-Fossuo CN, Rose AN, Elwood HR, Stepenaskie S, Barbosa NS. Surgical margin mapping of melanoma In situ using in vivo reflectance confocal microscopy mosaics. Dermatol Surg. 2021;47(5):605-8.
Felton S, Taylor RS, Srivastava D. Excision margins for melanoma in situ on the head and neck. Dermatol Surg. 2016;42(3):327-34.
Foxton GC, Elliott TG, Litterick KA. Treating melanoma in situ and lentigo maligna with Mohs micrographic surgery in Australia. Australas J Dermatol. 2019;60(1):33-7.
Glazer ES, Porubsky CF, Francis JD, Ibanez J, Castner N, Messina JL, et al. Treatment of head and neck melanoma in situ with staged contoured marginal excisions. Ann Plast Surg. 2017;78(6):663-7.
Kunishige JH, Brodland DG, Zitelli JA. Surgical margins for melanoma in situ. J Am Acad Dermatol. 2012;66(3):438-44.
Möller MG, Pappas-Politis E, Zager JS, Santiago LA, Yu D, Prakash A, et al. Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol. 2009;16(6):1526-36.
Olamiju B, Suozzi KC, Leffell DJ, Christensen SR. Clinical factors impacting clear margins of primary melanoma in situ with conventional excision in a retrospective cohort. J Am Acad Dermatol. 2021;86:966-7.
Bhardwaj SS, Tope WD, Lee PK. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience. Dermatol Surg. 2006;32(5):690-6; discussion 6-7.
Cohen LM, McCall MW, Hodge SJ, Freedman JD, Callen JP, Zax RH. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections. Cancer. 1994;73(12):2964-70.
Malhotra R, Chen C, Huilgol SC, Hill DC, Selva D. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma. Ophthalmology. 2003;110(10):2011-8.
Demer AM, Vance KK, Cheraghi N, Reich HC, Lee PK. Benefit of Mohs micrographic surgery over wide local excision for melanoma of the head and neck: a rational approach to treatment. Dermatol Surg. 2019;45(3):381-9.
Gao JM, Garioch JJ, Fadhil M, Tan E, Shah N, Moncrieff M. Planning slow Mohs excision margins for lentigo maligna: a retrospective nonrandomized cohort study comparing reflectance confocal microscopy margin mapping vs. visual inspection with dermoscopy. Br J Dermatol. 2021;184(6):1182-3.
Hilari H, Llorca D, Traves V, Villanueva A, Serra-Guillén C, Requena C, et al. Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases. Actas Dermosifiliogr. 2012;103(7):614-23.
Hou JL, Reed KB, Knudson RM, Mirzoyev SA, Lohse CM, Frohm ML, et al. Five-year outcomes of wide excision and Mohs micrographic surgery for primary lentigo maligna in an academic practice cohort. Dermatol Surg. 2015;41(2):211-8.
Moehrle M, Dietz K, Garbe C, Breuninger H. Conventional histology vs. three-dimensional histology in lentigo maligna melanoma. Br J Dermatol. 2006;154(3):453-9.
Ständer S, Assmann K, Nashan D, Wigbels B, Luger T, Metze D. Control of section margins without any gaps in paraffin sections of melanoma of the face. Hautarzt. 2000;51(11):826-32.
Walling HW, Scupham RK, Bean AK, Ceilley RI. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol. 2007;57(4):659-64.
Collgros H, Rodriguez-Lomba E, Regio Pereira A, Lo SN, Scolyer RA, Guitera P. Lentiginous melanoma (lentigo maligna and lentigo maligna melanoma) in Australia: clinicopathological characteristics, management and recurrence rates after 10-year follow-up at a tertiary centre. J Eur Acad Dermatol Venereol. 2021;35(6):1315-22.
Wilson JB, Walling HW, Scupham RK, Bean AK, Ceilley RI, Goetz KE. Staged excision for lentigo maligna and lentigo maligna melanoma: analysis of surgical margins and long-term recurrence in 68 cases from a single practice. J Clin Aesthet Dermatol. 2016;9(6):25-30.
Lawrence CM, Rahim R, Charlton F, Husain A. Prospective study of formalin-fixed Mohs surgery and haematoxylin and eosin stains with control contralateral biopsies for lentigo maligna: 5-year follow-up results. Br J Dermatol. 2014;171(2):298-303.
Bub JL, Berg D, Slee A, Odland PB. Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up. Arch Dermatol. 2004;140(5):552-8.
Hill DC, Gramp AA. Surgical treatment of lentigo maligna and lentigo maligna melanoma. Australas J Dermatol. 1999;40(1):25-30.
Hazan C, Dusza SW, Delgado R, Busam KJ, Halpern AC, Nehal KS. Staged excision for lentigo maligna and lentigo maligna melanoma: a retrospective analysis of 117 cases. J Am Acad Dermatol. 2008;58(1):142-8.
Kassi K, Vanwijck R, Kanga JM. The “collerette” technique for skin excision and biopsy: an efficient method for managing lentigo maligna of the head and neck. Int J Dermatol. 2014;53(7):899-903.
Robinson JK. Margin control for lentigo maligna. J Am Acad Dermatol. 1994;31(1):79-85.
Jejurikar SS, Borschel GH, Johnson TM, Lowe L, Brown DL. Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control. Plast Reconstr Surg. 2007;120(5):1249-55.
Navarrete-Dechent C, Aleissa S, Connolly K, Hibler BP, Dusza SW, Rossi AM, et al. Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type. J Am Acad Dermatol. 2021;84(5):1295-301.
Crouch G, Sinha S, Lo S, Saw RPM, Lee KK, Stretch J, et al. Clinical outcomes following surgical treatment of lentigo maligna of the head and neck. Eur J Surg Oncol. 2021;47(5):1145-51.
Elshot YS, Zupan-Kajcovski B, Klop WMC, Bekkenk MW, Crijns MB, Rie MA, et al. Handheld reflectance confocal microscopy: personalized and accurate presurgical delineation of lentigo maligna (melanoma). Head Neck. 2021;43(3):895-902.
Huilgol SC, Selva D, Chen C, Hill DC, James CL, Gramp A, et al. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. Arch Dermatol. 2004;140(9):1087-92.
Moura FS, Homer LE, McKirdy SW. Histological peripheral margins and recurrence of melanoma in situ treated with wide local excision. J Skin Cancer. 2020;2020:8813050.
Osborne JE, Hutchinson PE. A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. Br J Plast Surg. 2002;55(8):611-5.
Abdelmalek M, Loosemore MP, Hurt MA, Hruza G. Geometric staged excision for the treatment of lentigo maligna and lentigo maligna melanoma: a long-term experience with literature review. Arch Dermatol. 2012;148(5):599-604.
Agarwal-Antal N, Bowen GM, Gerwels JW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J Am Acad Dermatol. 2002;47(5):743-8.
Champin J, Perrot JL, Cinotti E, Labeille B, Douchet C, Parrau G, et al. In vivo reflectance confocal microscopy to optimize the spaghetti technique for defining surgical margins of lentigo maligna. Dermatol Surg. 2014;40(3):247-56.
Lee MR, Ryman WJ. Treatment of lentigo maligna with total circumferential margin control using vertical and horizontal permanent sections: a retrospective study. Australas J Dermatol. 2008;49(4):196-201.
Liu A, Botkin A, Murray C, Solish N, Kitchen J, Chan AW. Outcomes of staged excision with circumferential en face margin control for lentigo maligna of the head and neck. J Cutan Med Surg. 2021;25(1):18-24.
Demirci H, Johnson TM, Frueh BR, Musch DC, Fullen DR, Nelson CC. Management of periocular cutaneous melanoma with a staged excision technique and permanent sections the square procedure. Ophthalmology. 2008;115(12):2295-300.e3.
Beveridge J, Taher M, Zhu J, Mahmood MN, Salopek TG. Staged margin-controlled excision (SMEX) for lentigo maligna melanoma in situ. J Surg Oncol. 2018;118(1):144-9.
Breuninger H, Schlagenhauff B, Stroebel W, Schaumburg-Lever G, Rassner G. Patterns of local horizontal spread of melanomas: consequences for surgery and histopathologic investigation. Am J Surg Pathol. 1999;23(12):1493-8.
Cinotti E, Belgrano V, Labeille B, Grivet D, Douchet C, Chauleur C, et al. In vivo and ex vivo confocal microscopy for the evaluation of surgical margins of melanoma. J Biophotonics. 2020;13(11):e202000179.
de Wet J, du Plessis PJ, Schneider JW. Lentigo Maligna of the head and neck: a retrospective study assessing surgical excision margins in a South African population. JAAD Int. 2022;7:169-76.
Mahoney MH, Joseph M, Temple CL. The perimeter technique for lentigo maligna: an alternative to Mohs micrographic surgery. J Surg Oncol. 2005;91(2):120-5.
Couty E, Tognetti L, Labeille B, Douchet C, Habougit C, Couzan C, et al. In vivo reflectance confocal microscopy combined with the ‘spaghetti technique’ for the identification of surgical margins of lentigo maligna: experience in 70 patients. J Eur Acad Dermatol Venereol. 2018;32(9):e366-8.
de Vries K, Greveling K, Prens LM, Munte K, Koljenović S, van Doorn MBA, et al. Recurrence rate of lentigo maligna after micrographically controlled staged surgical excision. Br J Dermatol. 2016;174(3):588-93.
Clayton BD, Leshin B, Hitchcock MG, Marks M, White WL. Utility of rush paraffin-embedded tangential sections in the management of cutaneous neoplasms. Dermatol Surg. 2000;26(7):671-8.
Cohen LM, McCall MW, Zax RH. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. A follow-up study. Dermatol Surg. 1998;24(6):673-7.
Newman J, Beal M, Schram SE, Lee PK. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: an update from the University of Minnesota. Dermatol Surg. 2013;39(12):1794-9.
Kunishige JH, Doan L, Brodland DG, Zitelli JA. Comparison of surgical margins for lentigo maligna versus melanoma in situ. J Am Acad Dermatol. 2019;81(1):204-12.
Bosbous MW, Dzwierzynski WW, Neuburg M. Staged excision of lentigo maligna and lentigo maligna melanoma: a 10-year experience. Plast Reconstr Surg. 2009;124(6):1947-55.
Smith H, Olabi B, Lam M, Patel A, Varma S. Ten years' experience using the Johnson square procedure for lentigo maligna. Br J Dermatol. 2019;181(3):602-4.
Yélamos O, Cordova M, Blank N, Kose K, Dusza SW, Lee E, et al. Correlation of handheld reflectance confocal microscopy with radial video mosaicing for margin mapping of lentigo maligna and lentigo maligna melanoma. JAMA Dermatol. 2017;153(12):1278-84.
Bennett RG. Commentary on “recurrence rate for melanoma excised by Mohs micrographic surgery without immunostaining”. Dermatol Surg. 2022;48(5):498-9.
Chambers M, Swetter SM, Baker C, Saunders E, Chapman MS. Topical imiquimod for lentigo maligna: survival analysis of 103 cases with 17 years follow-up. J Drugs Dermatol. 2021;20(3):346-8.
Tio D, van der Woude J, Prinsen CAC, Jansma EP, Hoekzema R, van Montfrans C. A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures. J Eur Acad Dermatol Venereol. 2017;31(4):616-24.
Lallas A, Moscarella E, Kittler H, Longo C, Thomas L, Zalaudek I, et al. Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna. Br J Dermatol. 2021;185(3):675-7.
Sampson BP, Bowen GM. Strategies for reducing final surgical defect sizes in the treatment of lentigo maligna. Dermatol Surg. 2020;46(4):537-45.
Walsh SB, Varma R, Raimer D, Keane JC, Cantor A, Theos A, et al. Utility of Wood's light in margin determination of melanoma in situ after excisional biopsy. Dermatol Surg. 2015;41(5):572-8.
Robinson JK. Use of digital epiluminescence microscopy to help define the edge of lentigo maligna. Arch Dermatol. 2004;140(9):1095-100.
Robert C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat Commun. 2020;11(1):3801.
Murphy ME, Brodland DG, Zitelli JA. Errors in the interpretation of Mohs histopathology sections over a 1-year fellowship. Dermatol Surg. 2008;34(12):1637-41.